TY - JOUR
TI - Intravenous thrombolysis for acute ischemic stroke in COVID-19 era: Still the same?
AU - Bakola, E.
AU - Giannopoulos, S.
JO - Acta Neurologica Scandinavica
PY - 2022
VL - 145
TODO - 2
SP - 125-126
PB - John Wiley and Sons Inc
SN - 0001-6314, 1600-0404
TODO - 10.1111/ane.13545
TODO - fibrinolytic agent;  fibrinolytic agent;  tissue plasminogen activator, acute ischemic stroke;  brain ischemia;  coronavirus disease 2019;  Editorial;  fibrinolytic therapy;  functional status;  hospitalization;  human;  mechanical thrombectomy;  National Institutes of Health Stroke Scale;  pandemic;  reperfusion;  brain ischemia;  cerebrovascular accident;  complication;  fibrinolytic therapy;  treatment outcome, Brain Ischemia;  COVID-19;  Fibrinolytic Agents;  Humans;  Ischemic Stroke;  SARS-CoV-2;  Stroke;  Thrombolytic Therapy;  Tissue Plasminogen Activator;  Treatment Outcome
TODO - null
ER -